These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1960870)

  • 21. [The role of polyol pathways in formation of diabetic cataracts].
    Sabasiński K; Andrzejewska-Buczko J
    Klin Oczna; 1997; 99(6):401-4. PubMed ID: 9685789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects on rat renal osmolytes of extended treatment with an aldose reductase inhibitor.
    Edmands S; Yancey PH
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Nov; 103(3):499-502. PubMed ID: 1363299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro.
    Jiang ZY; Zhou QL; Eaton JW; Koppenol WH; Hunt JV; Wolff SP
    Biochem Pharmacol; 1991 Aug; 42(6):1273-8. PubMed ID: 1909528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites.
    El-Kabbani O; Podjarny A
    Cell Mol Life Sci; 2007 Aug; 64(15):1970-8. PubMed ID: 17497245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldose reductase inhibitors.
    Oka M; Kato N
    J Enzyme Inhib; 2001 Dec; 16(6):465-73. PubMed ID: 12164386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.
    Srivastava SK; Ansari NH; Hair GA; Awasthi S; Das B
    Metabolism; 1986 Apr; 35(4 Suppl 1):114-8. PubMed ID: 3083202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of non-enzymatic glycation on recombinant human aldose reductase.
    Yamaoka T; Oda A; Bannai C; Itakura M; Yamashita K
    Diabetes Res Clin Pract; 1995 Mar; 27(3):165-9. PubMed ID: 7555597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldose reductase: black sheep or skeleton in the cupboard?
    Crabbe MJ; Goode D; Wolff SP
    Nat Struct Biol; 1996 Aug; 3(8):659-61. PubMed ID: 8756319
    [No Abstract]   [Full Text] [Related]  

  • 29. Aldose reductase from human skeletal and heart muscle. Interconvertible forms related by thiol-disulfide exchange.
    Vander Jagt DL; Robinson B; Taylor KK; Hunsaker LA
    J Biol Chem; 1990 Dec; 265(34):20982-7. PubMed ID: 2174432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldose reductase activity in a cultured human retinal cell line.
    Russell P; Merola LO; Yajima Y; Kinoshita JH
    Exp Eye Res; 1982 Oct; 35(4):331-6. PubMed ID: 6814942
    [No Abstract]   [Full Text] [Related]  

  • 31. Hydantoin bioisosteres. In vivo active spiro hydroxy acetic acid aldose reductase inhibitors.
    Lipinski CA; Aldinger CE; Beyer TA; Bordner J; Burdi DF; Bussolotti DL; Inskeep PB; Siegel TW
    J Med Chem; 1992 Jun; 35(12):2169-77. PubMed ID: 1613744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of aldose reductase inhibitors on the metabolism of cultured monkey kidney epithelial cells.
    Boot-Handford R; Heath H
    Biochem Pharmacol; 1981 Nov; 30(22):3065-9. PubMed ID: 6802136
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of fluoro- and deoxy-substrate analogs to examine binding specificity and catalysis in the enzymes of the sorbitol pathway.
    Scott ME; Viola RE
    Carbohydr Res; 1998 Dec; 313(3-4):247-53. PubMed ID: 10209867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-Idose: an attractive substrate alternative to D-glucose for measuring aldose reductase activity.
    Balestri F; Cappiello M; Moschini R; Rotondo R; Buggiani I; Pelosi P; Mura U; Del-Corso A
    Biochem Biophys Res Commun; 2015 Jan; 456(4):891-5. PubMed ID: 25528584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The biochemical basis of the complications of diabetes].
    Gabbay KH
    Journ Annu Diabetol Hotel Dieu; 1984; ():307-20. PubMed ID: 6443221
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibitory effect of glucodistylin from the bark of Quercus acutissima on human recombinant aldose reductase and sorbitol accumulation.
    Lee YS; Kim JK; Bae YS; Won MH; Kang IJ; Lim SS
    Arch Pharm Res; 2011 Feb; 34(2):211-5. PubMed ID: 21380803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of aldose reductase in the progression of diabetic retinopathies].
    Akagi Y; Kubo E
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():194-201. PubMed ID: 15999706
    [No Abstract]   [Full Text] [Related]  

  • 38. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications.
    Giannoukakis N
    Expert Opin Investig Drugs; 2008 Apr; 17(4):575-81. PubMed ID: 18363521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The collagen hydration hypothesis: a new paradigm for the secondary complications of diabetes mellitus.
    Eaton RP
    J Chronic Dis; 1986; 39(10):763-6. PubMed ID: 3093515
    [No Abstract]   [Full Text] [Related]  

  • 40. The failure of aldose reductase inhibitor 3,3'-tetramethylene glutaric acid to inhibit in vivo sorbitol accumulation in lens and retina in diabetes.
    Hutton JC; Schofield PJ; Williams JF; Hollows FC
    Biochem Pharmacol; 1974 Nov; 23(21):2991-8. PubMed ID: 4279667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.